8-K/A: Current report filing
Published on October 27, 2008
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 1
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): November 28,
2007
OPKO
Health, Inc.
(Exact
Name of Registrant as Specified in Charter)
|
|
|
|
|
|
|
Delaware
|
|
000-26648
|
|
75-2402409
|
|
(State
or other
jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
4400
Biscayne Blvd
Suite 1180
Miami,
Florida 33137
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (305) 575-4138
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
EXPLANATORY
NOTE
OPKO
Health, Inc. (the “Company”) is filing this Amendment No. 1 to its Current
Report on Form 8-K that was initially filed with the Securities and Exchange
Commission on November 29, 2007 in connection with the Company's acquisition
of
Ophthalmic Technologies, Inc. (this “Amendment”). This Amendment includes the
audited and pro forma financial information required by Item 9.01 of Form 8-K.
|
ITEM
9.01.
|
|
Financial
Statements and Exhibits.
|
|
(a)
|
Financial
Statements of Business Acquired
|
The
following financial statements of OTI are being filed with this report as
Exhibit 99.1:
|
Consolidated
Balance Sheets of OTI as of April 30, 2007 and April 30,
2006
|
|
Statements
of Operations and Deficit and Cash Flows for the years ended April
30,
2007 and April 30, 2006
|
|
(b)
|
Pro
Forma Financial Information
|
The
following pro forma financial information is being filed with this report as
Exhibit 99.2:
Unaudited
Pro Forma Condensed Consolidated Balance Sheet as of September 30,
2007
Unaudited
Pro Forma Condensed Consolidated Statement of Operations for the period from
inception (June 23, 2006) to December 31, 2006.
Unaudited
Pro Forma Condensed Consolidated Statement of Operations for the nine
months ended September 30, 2007
|
|
(c)
|
Not Applicable
|
|
|
(d)
|
Exhibits
|
| No. | Description | |
|
|
23.1
|
Consent
of Deloitte & Touche LLP
|
|
|
99.1(1)
|
Financial
Statements listed in Item 9.01(a)
|
|
99.2
|
Pro
Forma Financial Information listed in Item 9.01(b)
|
|
|
(1)
|
Filed
with the Company’s Current Report on Form 8-K/A filed on October 24, 2008
and incorporated herein by
reference
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
|
OPKO
Health, Inc.
|
|
||
|
|
By
/s/ Adam
Logal
|
|
||
|
|
Name:
|
Adam
Logal
|
|
|
|
|
Title:
|
Executive
Director of Finance, Chief Accounting Officer,
Treasurer
|
|
|
|
|
||||
Date:
October 24, 2008
Exhibit
Index
| No. | Description |
|
|
23.1
|
Consent
of Deloitte & Touche LLP
|
|
99.2
|
Pro
Forma Financial Information listed in Item
9.01(b)
|